D-0615-2017 Class II Terminated
FDA drug recall D-0615-2017 was initiated by Claris Lifesciences Inc on Mar 10, 2017 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product. The recall status is terminated (terminated Sep 18, 2020). Affected quantity: 24,456 units (1019 cartons x 24 bags).
Recall details
- Product Type
- Drugs
- Report Date
- Apr 5, 2017
- Initiation Date
- Mar 10, 2017
- Termination Date
- Sep 18, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24,456 units (1019 cartons x 24 bags)
Product description
Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-048-24
Reason for recall
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Distribution pattern
Nationwide
Code information
Lot #: A060040, Exp. Dec 2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0615-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026